Accueil > Actualité
Actualite financiere : Actualite bourse

BioMérieux: CE marking of a vitamin B12 test

(CercleFinance.com) - bioMérieux has announced the CE marking of VIDAS VITAMIN B12 TOTAL, an automated quantitative test running on its VIDAS immunoassay platform for measuring total vitamin B12 concentration in human serum or plasma.


"Measuring vitamin B12 levels can help optimize patient management, as deficiency can be linked to anemia or neurological symptoms, including cognitive difficulties or altered gait", stresses the group.

Found mainly in animal food products, vitamin B12 is necessary for the normal functioning of the central nervous system, DNA synthesis and the proper development of red blood cells.

The in vitro diagnostics specialist expects the VIDAS VITAMIN B12 TOTAL test to be commercially launched in selected countries by the end of 2024, before wider deployment in the first quarter of 2025.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.